A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567.

Clinical trial NCT02512575 · COMPLETED

Trial details

NCT number: NCT02512575
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety Tolerability Pharmacokinetics Pharmacodynamics Healthy Subjects Rheumatoid Arthritis

Start date: 2015-11-18
Primary completion: 2016-09-26
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.